** Shares of drugmaker SpringWorks Therapeutics SWTX.O rise 8.2% to $44.59
** Germany's Merck KGaA MRCG.DE is nearing a roughly $3.5 billion deal for SWTX, the Wall Street Journal reports
** Both companies have agreed on a price close to $47 per share, report says
** Up to last close, SWTX up 14% YTD
(Reporting by Juby Babu in Mexico City)
((Juby.Babu@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.